3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
4
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Stomach Neoplasms
1
Skin Diseases
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Multiple Myeloma
1
Lymphoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Diseases
1
Advanced Unresectable or Metastatic Solid Malignancy
1
Interventions
Cisplatin
7
Cetuximab
6
Radiotherapy, Intensity-Modulated
4
pembrolizumab
3
durvalumab
3
Radiotherapy
2
Radiation
2
Observation
2
Drug Therapy
2
Celecoxib
2
Bupropion
2
130-nm albumin-bound paclitaxel
2
trametinib
1
sodium thiosulfate
1
gluconic acid
1
ficlatuzumab
1
Zinc
1
Watchful Waiting
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Tadalafil
1
Sirolimus
1
RRx-001
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Photochemotherapy
1
Periodontal Debridement
1
Oral Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mouth Neoplasms
×
ipatasertib
×
Clear all
No trials found.